The 10 most pop­u­lar sto­ries in End­points News — so far in 2017

Since Ar­salan Arif and I ramped up the main edi­tion of End­points News 16 months ago, we’ve pub­lished more than a mil­lion words on bio­phar­ma R&D.

Tol­stoy, eat your heart out.

This year we’ve in­creased web traf­fic, track­ing close to an av­er­age of 20,000 read­ers per day — with more than 22,000 email sub­scribers — which is con­sid­er­ably high­er than where we start­ed in the mid­dle of 2016.

So what are bio­phar­ma peo­ple read­ing in End­points?

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER